Genetic Testing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
The study predicts the short term and long term trends that can shape up the future of the Genetic Testing market including the COVID-19 pandemic implications for Genetic Testings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.
The Genetic Testing market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Genetic Testing Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Genetic Testing market forecast and Genetic Testing market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023- 2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Genetic Testing market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Genetic Testing industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Genetic Testing market share in developed countries.
Scope of the research-
Global Genetic Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By type including
Predictive and Presymptomatic Testing
Carrier Testing
Prenatal and Newborn Testing
Diagnostic Testing
Pharmacogenomic Testing
Others
Global Genetic Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By technology including
Cytogenetic Testing
Biochemical Testing
Molecular Testing
Others
Global Genetic Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By Disease
Alzheimer
Oncology
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular
Thalassemia
Huntingtons Disease
Rare Disease
Others
Top Companies Operating in Genetic Testing market include- 23 and Me , Abbott Laboratories , Bio-Rad Laboratories , Danaher Corporation , Eurofins Scientific , Genesis Healthcare , Illumina , Luminex Corporation , Myriad Genetics , Precipio
The Genetic Testing market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Genetic Testing Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Genetic Testing market forecast and Genetic Testing market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023- 2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Genetic Testing market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Genetic Testing industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Genetic Testing market share in developed countries.
Scope of the research-
Global Genetic Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By type including
Predictive and Presymptomatic Testing
Carrier Testing
Prenatal and Newborn Testing
Diagnostic Testing
Pharmacogenomic Testing
Others
Global Genetic Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By technology including
Cytogenetic Testing
Biochemical Testing
Molecular Testing
Others
Global Genetic Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By Disease
Alzheimer
Oncology
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular
Thalassemia
Huntingtons Disease
Rare Disease
Others
Top Companies Operating in Genetic Testing market include- 23 and Me , Abbott Laboratories , Bio-Rad Laboratories , Danaher Corporation , Eurofins Scientific , Genesis Healthcare , Illumina , Luminex Corporation , Myriad Genetics , Precipio
1. TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2. EXECUTIVE SUMMARY
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Genetic Testing Market- Key Findings, 2022
3. STRATEGIC IMPERATIVES ON GLOBAL GENETIC TESTING MARKET
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Genetic Testing Companies
4. GLOBAL GENETIC TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY TYPE
4.1 Predictive and Presymptomatic Testing
4.2 Carrier Testing
4.3 Prenatal and Newborn Testing
4.4 Diagnostic Testing
4.5 Pharmacogenomic Testing
4.6 Others
5. GLOBAL GENETIC TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY TECHNOLOGY
5.1 Cytogenetic Testing
5.2 Biochemical Testing
5.3 Molecular Testing
5.4 Others
6. GLOBAL GENETIC TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY DISEASE
6.1 Alzheimer
6.2 Oncology
6.3 Cystic Fibrosis
6.4 Sickle Cell Anemia
6.5 Duchenne Muscular
6.6 Thalassemia
6.7 Huntingtons Disease
6.8 Rare Disease
6.9 Others
7 ASIA PACIFIC GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
7.1 Leading Genetic Testing Types contributing to Asia Pacific market
7.2 Top Applications contributing to Asia Pacific Genetic Testing
7.3 Top countries contributing to Asia Pacific Genetic Testing
8 EUROPE GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
8.1 Leading Genetic Testing Types contributing to Europe market
8.2 Top Applications contributing to Europe Genetic Testing
8.3 Top countries contributing to Europe Genetic Testing
9 NORTH AMERICA GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
9.1 Leading Genetic Testing Types contributing to North America market
9.2 Top Applications contributing to North America Genetic Testing
9.3 Top countries contributing to North America Genetic Testing
10 SOUTH AND CENTRAL AMERICA GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
10.1 Leading Genetic Testing Types contributing to South and Central America market
10.2 Top Applications contributing to South and Central America Genetic Testing
10.3 Top countries contributing to South and Central America Genetic Testing
11 MIDDLE EAST AFRICA GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
11.1 Leading Genetic Testing Types contributing to Middle East Africa market
11.2 Top Applications contributing to Middle East Africa Genetic Testing
11.3 Top countries contributing to Middle East Africa Genetic Testing
12 BUSINESS PROFILES OF LEADING COMPANIES
12.1 Business Description, SWOT and Financial Analysis of Companies in Genetic Testing market
12.2 23 and Me
12.3 Abbott Laboratories
12.4 Bio-Rad Laboratories
12.5 Danaher Corporation
12.6 Eurofins Scientific
12.7 Genesis Healthcare
12.8 Illumina
12.9 Luminex Corporation
12.10 Myriad Genetics
12.11 Precipio
13 RECENT INDUSTRY DEVELOPMENTS
14 APPENDIX
14.1 OGAnalysis Expertise
14.2 Sources and Methodology
14.3 Contacts
1.1 List of Tables
1.2 List of Figures
2. EXECUTIVE SUMMARY
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Genetic Testing Market- Key Findings, 2022
3. STRATEGIC IMPERATIVES ON GLOBAL GENETIC TESTING MARKET
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Genetic Testing Companies
4. GLOBAL GENETIC TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY TYPE
4.1 Predictive and Presymptomatic Testing
4.2 Carrier Testing
4.3 Prenatal and Newborn Testing
4.4 Diagnostic Testing
4.5 Pharmacogenomic Testing
4.6 Others
5. GLOBAL GENETIC TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY TECHNOLOGY
5.1 Cytogenetic Testing
5.2 Biochemical Testing
5.3 Molecular Testing
5.4 Others
6. GLOBAL GENETIC TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY DISEASE
6.1 Alzheimer
6.2 Oncology
6.3 Cystic Fibrosis
6.4 Sickle Cell Anemia
6.5 Duchenne Muscular
6.6 Thalassemia
6.7 Huntingtons Disease
6.8 Rare Disease
6.9 Others
7 ASIA PACIFIC GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
7.1 Leading Genetic Testing Types contributing to Asia Pacific market
7.2 Top Applications contributing to Asia Pacific Genetic Testing
7.3 Top countries contributing to Asia Pacific Genetic Testing
8 EUROPE GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
8.1 Leading Genetic Testing Types contributing to Europe market
8.2 Top Applications contributing to Europe Genetic Testing
8.3 Top countries contributing to Europe Genetic Testing
9 NORTH AMERICA GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
9.1 Leading Genetic Testing Types contributing to North America market
9.2 Top Applications contributing to North America Genetic Testing
9.3 Top countries contributing to North America Genetic Testing
10 SOUTH AND CENTRAL AMERICA GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
10.1 Leading Genetic Testing Types contributing to South and Central America market
10.2 Top Applications contributing to South and Central America Genetic Testing
10.3 Top countries contributing to South and Central America Genetic Testing
11 MIDDLE EAST AFRICA GENETIC TESTING MARKET VALUE OUTLOOK TO 2030
11.1 Leading Genetic Testing Types contributing to Middle East Africa market
11.2 Top Applications contributing to Middle East Africa Genetic Testing
11.3 Top countries contributing to Middle East Africa Genetic Testing
12 BUSINESS PROFILES OF LEADING COMPANIES
12.1 Business Description, SWOT and Financial Analysis of Companies in Genetic Testing market
12.2 23 and Me
12.3 Abbott Laboratories
12.4 Bio-Rad Laboratories
12.5 Danaher Corporation
12.6 Eurofins Scientific
12.7 Genesis Healthcare
12.8 Illumina
12.9 Luminex Corporation
12.10 Myriad Genetics
12.11 Precipio
13 RECENT INDUSTRY DEVELOPMENTS
14 APPENDIX
14.1 OGAnalysis Expertise
14.2 Sources and Methodology
14.3 Contacts
